Beyond instrument horsepower, enabling solutions are needed more than ever to ensure quality and efficiency of upstream workflows. Here are recent examples.
Advances in efficiency, precision, reliability, and scalability are critical to meet increasingly stringent guidelines and overall growth of the industry.
Several important developments in 2017 offer promise for significant advancement in the area of clinical mass spectrometry.
2017 has seen the launch of several breakthrough clinical LC-MS technologies, driving new areas of clinical exploration and anticipation for what's to come.